Page last updated: 2024-10-26

dipyridamole and Endometriosis

dipyridamole has been researched along with Endometriosis in 1 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Endometriosis: A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pimenova, LI1
Teteliutina, FK1
Serebrennikova, GK1
Starostin, SV1
Churshin, AD1

Other Studies

1 other study available for dipyridamole and Endometriosis

ArticleYear
[Conservative therapy of genital endometriosis].
    Sovetskaia meditsina, 1989, Issue:7

    Topics: Adult; Dipyridamole; Drug Combinations; Drug Therapy, Combination; Endometriosis; Estrogens; Female;

1989